Cardiac impedance in hypertension treatment Review article
Article Sidebar
Main Article Content
Abstract
Various hemodynamic parameters determine preload, afterload, myocardial contractility, the amount of circulating blood and the mechanical properties of the arterial system. Number of hemodynamic parameters like stroke volume, cardiac output or systemic vascular resistance can be measured non-invasively by cardiac impedance. These hemodynamic variables define arterial blood pressure level and their modification is helpful in the selection of pharmacological therapy of hypertension. Reports from several clinical studies show that antihypertensive therapy based on hemodynamic measurements by cardiac impedance is more effective than recommendation-based treatment in achieving blood pressure <140/90 mmHg.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Blood Pressure Lowering Treatment Trialists Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003, 362: 1527-1545.
3. De Maria A.N., Raisinghani A.: Comparative overview of cardiac output measurement methods: has impedance cardiography come of age? Congest Heart Fail. 2000, 6: 60-73.
4. Drazner M.H., Thompson B., Rosenberg P.B., Kaiser P.A., Boehrer J.D., Baldwin B.J., Dries D.L., Yancy C.W.: Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. Am. J. Cardiol. 2002, 89: 993-995.
5. Ezzati M., Lopez A.D., Rodgers A., Vander Hoorn S., Murray C.J.; Comparative Risk Assessment Collaborating Group: Selected major risk factors and global and regional burden of disease. Lancet 2002, 360: 1347-1360.
6. Ferrario C.M., Flack J.M., Strobeck J.E., Smits G., Peters C.: Individualizing hypertension treatment with impedance cardiography: a meta-analysis of published trials. Ther. Adv. Cardiovasc. Dis. 2010, 4: 5-16.
7. Krupa- Wojciechowska B., Zdrojewski T.: Nadciśnienie tętnicze 2003. Przewodnik lekarza 2003, 6: 16-25.
8. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., Grassi G., Heagerty A.M., Kjeldsen S.E., Laurent S., Narkiewicz K., Ruilope L., Rynkiewicz A., Schmieder R.E., Boudier H.A., Zanchetti A., Vahanian A., Camm J., De Caterina R., Dean V., Dickstein K., Filippatos G., Funck-Brentano C., Hellemans I., Kristensen S.D., McGregor K., Sechtem U., Silber S., Tendera M., Widimsky P., Zamorano J.L., Erdine S., Kiowski W., Agabiti-Rosei E., Ambrosioni E., Lindholm L.H., Viigimaa M., Adamopoulos S., Agabiti-Rosei E., Ambrosioni E., Bertomeu V., Clement D., Erdine S., Farsang C., Gaita D., Lip G., Mallion J.M., Manolis A.J., Nilsson P.M., O’Brien E., Ponikowski P., Redon J., Ruschitzka F., Tamargo J., van Zwieten P., Waeber B., Williams B.; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2007, 25: 1105-1187.
9. Mancia G., Laurent S., Agabiti-Rosei E., Ambrosioni E., Burnier M., Caulfield M.J., Cifkova R., Clément D., Coca A., Dominiczak A., Erdine S., Fagard R., Farsang C., Grassi G., Haller H., Heagerty A., Kjeldsen S.E., Kiowski W., Mallion J.M., Manolis A., Narkiewicz K., Nilsson P., Olsen M.H., Rahn K.H., Redon J., Rodicio J., Ruilope L., Schmieder R.E., Struijker-Boudier H.A., van Zwieten P.A., Viigimaa M., Zanchetti A.: Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J. Hypertens. 2009, 27: 2121-2158.
10. Middeke M.: Nadciśnienie tętnicze. Wydawnictwo Czelej, Lublin 2009.
11. Sageman W.S., Riffenburgh R.H., Spiess B.D.: Equivalence of bioimpedance and thermodilution in measuring cardiac index after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2002, 16: 8-14.
12. Smith R.D., Levy P., Ferrario C.M.; Consideration of Noninvasive Hemodynamic Monitoring to Target Reduction of Blood Pressure Levels Study Group. Value of noninvasive hemodynamics to achieve blood pressure control in hypertensive subjects. Hypertension 2006, 47: 771-777.
13. Strobeck J.E., Silver M.A., Ventura H.: Impedance cardiography: noninvasive measurement of cardiac stroke volume and thoracic fluid content. Congest. Heart Fail. 2000, 6: 56-59.
14. Taler S.J., Textor S.C., Augustine J.E.: Resistant hypertension: Comparing hemodynamic management to specialist care. Hypertension 2002, 39: 982-988.
15. Van De Water J.M., Miller T.W., Vogel R.L., Mount B.E., Dalton M.L.: Impedance cardiography: the next vital sign technology? Chest 2003, 123: 2028-33.
16. Wang Y., Wang Q.J.: The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch. Intern. Med. 2004, 164: 2126-2134.
17. Yakovlevitch M., Black H.R.: Resistant hypertension in a tertiary care clinic. Arch. Intern. Med. 1991, 151: 1786-1792.